1. Home
  2. FLNG vs ANIP Comparison

FLNG vs ANIP Comparison

Compare FLNG & ANIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo FLEX LNG Ltd.

FLNG

FLEX LNG Ltd.

HOLD

Current Price

$30.66

Market Cap

1.7B

ML Signal

HOLD

Logo ANI Pharmaceuticals Inc.

ANIP

ANI Pharmaceuticals Inc.

HOLD

Current Price

$78.47

Market Cap

1.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FLNG
ANIP
Founded
2006
2001
Country
Bermuda
United States
Employees
N/A
N/A
Industry
Marine Transportation
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.9B
IPO Year
2019
1999

Fundamental Metrics

Financial Performance
Metric
FLNG
ANIP
Price
$30.66
$78.47
Analyst Decision
Hold
Strong Buy
Analyst Count
1
5
Target Price
$23.00
$110.00
AVG Volume (30 Days)
376.6K
274.5K
Earning Date
05-13-2026
05-08-2026
Dividend Yield
9.40%
N/A
EPS Growth
N/A
419.23
EPS
N/A
1.28
Revenue
N/A
$206,547,000.00
Revenue This Year
N/A
$21.01
Revenue Next Year
$2.14
$17.59
P/E Ratio
$19.72
$61.35
Revenue Growth
N/A
2.47
52 Week Low
$23.66
$62.61
52 Week High
$33.40
$99.50

Technical Indicators

Market Signals
Indicator
FLNG
ANIP
Relative Strength Index (RSI) 51.34 41.72
Support Level $30.60 $76.92
Resistance Level $31.31 $83.66
Average True Range (ATR) 0.83 2.38
MACD 0.10 -0.59
Stochastic Oscillator 62.63 18.11

Price Performance

Historical Comparison
FLNG
ANIP

About FLNG FLEX LNG Ltd.

Flex LNG Ltd is an LNG shipping company with a fleet of next-generation LNG carriers with large cargo capacity. The company's fleet consists of several LNG carriers on the water, and all of its vessels are of the latest generation equipped with two-stroke propulsion. Its fleet consists of M-type, Electronically Controlled, Gas Injection (MEGI) LNG carriers and Generation X Dual Fuel (X-DF) LNG carriers, offering improvements in fuel efficiency and thus also carbon footprint compared to the older steam and four-stroke propelled ships. The company has one reportable segment: vessel operations, which generates revenue from the chartering of vessels to customers.

About ANIP ANI Pharmaceuticals Inc.

ANI Pharmaceuticals Inc is a diversified biopharmaceutical company. It is focused on developing, manufacturing, and commercializing therapeutics through its Rare Disease business, which markets novel products in the areas of ophthalmology, rheumatology, nephrology, neurology, and pulmonology; and through its Generics and Brands businesses. The firm's product portfolio comprises Purified Cortrophin Gel, ILUVIEN, and YUTIQ (fluocinolone acetonide intravitreal implant), among others. Additionally, its Generics portfolio includes several products with a wide variety of indications. The company has two operating segments: Rare Disease and Brands, which derive maximum revenue, and Generics and Other. Geographically, it generates maximum revenue from the United States, followed by other markets.

Share on Social Networks: